| pubmed-article:21404144 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21404144 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:21404144 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:21404144 | lifeskim:mentions | umls-concept:C0050672 | lld:lifeskim |
| pubmed-article:21404144 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:21404144 | pubmed:dateCreated | 2011-3-15 | lld:pubmed |
| pubmed-article:21404144 | pubmed:abstractText | Actovegin(®) is a biological drug manufactured from a natural source: it is a calf blood hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can be summarized to a common goal, i.e. the enhancement of cellular metabolism; this results from an insulin-like activity mediated by Inositol-phospho-oligosaccharides. Actovegin(®) results in beneficial effects in several pathophysiological clinical settings including malfunction of the blood circulation and trophic disturbances in the brain, impairment of peripheral blood circulation and associated diseases, dermal transplants and acute and chronic wounds. Here, we give an overview of the pharmacodynamic actions of calf-blood hemidialysate and its beneficial effects in a variety of clinical settings. | lld:pubmed |
| pubmed-article:21404144 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21404144 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21404144 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21404144 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:21404144 | pubmed:issn | 1563-258X | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:SitteHarald... | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:PleinerJohann... | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:ElmlingerMart... | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:LauerGereonG | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:BuchmayerFlor... | lld:pubmed |
| pubmed-article:21404144 | pubmed:author | pubmed-author:NellGerfriedG | lld:pubmed |
| pubmed-article:21404144 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21404144 | pubmed:volume | 161 | lld:pubmed |
| pubmed-article:21404144 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21404144 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21404144 | pubmed:pagination | 80-8 | lld:pubmed |
| pubmed-article:21404144 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:meshHeading | pubmed-meshheading:21404144... | lld:pubmed |
| pubmed-article:21404144 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21404144 | pubmed:articleTitle | Actovegin®: a biological drug for more than 5 decades. | lld:pubmed |
| pubmed-article:21404144 | pubmed:affiliation | Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria. | lld:pubmed |
| pubmed-article:21404144 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21404144 | pubmed:publicationType | Review | lld:pubmed |
